The National Neuroscience Institute (NNI), Singapore is the national specialist centre and regional centre for clinical referrals for the management and treatment of the neurosciences, as well as for education and research conducted in the field. NNI offers over 20 subspecialties in neuroscience care and treats a broad range of illness affecting the brain, spine, nerves and muscles. Offering a comprehensive range of Neurology, Neurosurgery and Neuroradiology services using the latest technology and experience of our healthcare professionals, NNI is at the forefront of neuroscience care in Singapore and across the region.
NNI operates from two campuses; Tan Tock Seng Hospital and Singapore General Hospital and provides specialty services to four partner hospitals: Changi General Hospital, Khoo Teck Puat Hospital, KK Women's and Children's Hospital and Sengkang General Hospital.
NNI is a member of the SingHealth Duke-NUS Academic Medical Centre.
As a centre of excellence, NNI comprises a team of specialist doctors, nurses and allied health professionals, who are highly trained to provide patients with quality patient care delivered through three clinical departments: Neurology, Neurosurgery and Neuroradiology.
NNI has established itself as a leader in neuroscience care in Asia with strong clinical services and multidisciplinary programmes. Our strengths lie especially in stroke, Parkinson disease and movement disorders, Alzheimer’s disease and dementia, epilepsy, and neuromuscular disorders. NNI manages the most number of neurology patients in Singapore and its Neurodiagnostic Laboratory provides these patients with care, support and latest technology to manage their neurological disorders.
NNI’s Neurosurgery Department is the largest in Singapore and often referred to as the “mother of neurosurgery” for having trained many of the practicing neurosurgeons in Singapore. Our neurosurgeons have been developing various subspecialty services and programmes for the various diseases, to improve clinical delivery. The co-ordinated subspecialties include trauma, oncology and skull base, neurovascular, functional, paediatric and spine neurosurgery programmes that are comparable to the top neurosurgical centres around the world. Together with SGH, NNI pioneered the world’s first digitally integrated neurosurgical centre to provide a full range of treatment options combined within one facility, using the latest in neuroimaging for better patient outcomes and results.
The NNI has the only specialised Neuroradiology department in Singapore that provides a subspecialised neuroradiology service to various hospitals in Singapore locally and across the region. It includes a specialised team of interventional neuroradiologists who, as pioneering practitioners in this field, carried out the first coiling of intracranial aneurysm in South East Asia. The department is equipped with a wide range of advanced neuro-imaging equipment, dedicated to producing high quality images of the brain and spine. Rapid advancements in information technology have also enabled the digitisation of medical imaging information. This development has made it possible for medical images to be easily displayed, transmitted and stored.
Education and Teaching
NNI has the reputation of providing the best neurological education in Singapore, and is the main training institution for neurosurgery and neuroradiology. We advanced our education mission through continued collaboration with both the National University of Singapore (NUS) and Duke-NUS Medical School to refine its curriculum and fine-tune neuroscience teaching. Students from both medical schools are posted to the Neurology departments for clinical teaching. Most of the Neurology Advanced Speciality Trainees (ASTs) in Singapore are also trained at NNI.
NNI’s Office of Neurological Education (ONE), which has been in the forefront of pioneering new teaching methods in this field in Singapore, continually refines its curriculum to be more effective and relevant for medical students.
The Institute is a major provider of Continuing Medical Education (CME) through its advanced training and conferences for healthcare professionals in Singapore, around the region and beyond.
NNI continues to advance its stature as a clinical and research centre by staying true to its mission to improve treatment and discover cures for neurological diseases. NNI research focuses on achieving better understanding of basic physiological and disease mechanisms, discovering and exploring new medical and surgical therapies, and improving healthcare provision and delivery. These have been further developed into cohesive signature “bench-to-bedside” programmes, with the ultimate aim of reducing the disease burden and to improve our clinical services and the patients’ quality of life.
About Singapore Health Services (SingHealth)
The SingHealth Duke-NUS Academic Medical Centre draws on the collective strengths of SingHealth and Duke-NUS Medical School to drive the transformation of healthcare and provide affordable, accessible, quality healthcare. With over 40 clinical specialties, a network of acute hospitals, national specialty centres, polyclinics and community hospitals, it delivers comprehensive, multi-disciplinary and integrated care. To enhance community care, the new Outram Community Hospital on SGH Campus will be completed in 2020.
For more information, please visit: www.singhealth.com.sg
Members of the SingHealth group
Hospitals (Tertiary Specialty Care):
Singapore General Hospital, Changi General Hospital, KK Women's and Children's Hospital, Sengkang General Hospital
National Specialty Centres (Tertiary Specialty Care):
National Cancer Centre Singapore, National Dental Centre Singapore, National Heart Centre Singapore, National Neuroscience Institute, and Singapore National Eye Centre
SingHealth Polyclinics (Primary Care):
Bedok, Bukit Merah, Marine Parade, Outram, Pasir Ris, Punggol, Sengkang, and Tampines
SingHealth Community Hospitals (Intermediate and Long-term Care):
Bright Vision Hospital, Sengkang Community Hospital, Outram Community Hospital (expected completion: 2020)
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.